THE EFFICACY AND SAFETY OF SUBCUTANEOUS (SC) ABATACEPT (ABA) IS CONSISTENT WITH THE ESTABLISHED INTRAVENOUS (IV) PROFILE IN A STUDY OF 1457 PATIENTS WITH RA AND AN INADEQUATE RESPONSE TO MTX (MTX-IR) Nash, P., Genovese, M., COVARRUBIAS, J., LEON, G., Mysler, E., Keiserman, M., Valante, R., Simon, J., PORAWSKA, W., Box, J., Leggerton, C., Nasonov, E., Durez, P., Aranda, R., Pappau, R., Delaet, I., Teng, J., Alten, R., Bamford, T. WILEY-BLACKWELL. 2011: 16–16

View details for Web of Science ID 000290489900053